Molecular cloning, tissue distribution, and effect of fasting and refeeding on the expression of neuropeptide Y in Channa argus
-
Add time:08/30/2019 Source:sciencedirect.com
Neuropeptide Y (NPY) is a 36 amino-acid amidated peptide of the pancreatic polypeptide (PP) family, which plays an important role in appetite regulation and energy expenditure in mammals. Although several teleost NPY have been identified, its roles remain unclear in fish. We herein reported on the molecular cloning, tissue distribution and the effect of fasting on the expression of NPY in Channa argus, and designated as CaNPY. It consisted of a 300 bp open reading frame predicted to encode a prepro-NPY of 99 amino acids. Sequence analysis revealed that CaNPY was highly conserved (>60%) with other vertebrate NPY. Phylogenetic analysis highly supported CaNPY was closely related to piscine NPY. In addition, except for muscle and spleen tissues, CaNPY was found to extensively expressed in all other detected tissues, with the highest level in brain. Futhermore, the CaNPY transcript was found to significantly increase after short-term and long-term food deprivation, and dramatically decrease following refeeding. These findings suggested that CaNPY might be involved in food intake regulation and it could be as a potential target locus to improve commercial production of this kind of fish.
We also recommend Trading Suppliers and Manufacturers of NEUROPEPTIDE Y (13-36) (PORCINE) (cas 113662-54-7). Pls Click Website Link as below: cas 113662-54-7 suppliers
Prev:SERS characterization of neuropeptide Y and its C-terminal fragments deposited onto colloidal gold nanoparticle surface
Next:Original ArticleWhat is the optimal dose of Clopidogrel (cas 113665-84-2) in paediatric patients?¿Cuál es la dosis óptima de Clopidogrel (cas 113665-84-2) en pacientes pediátricos?☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- SERS characterization of neuropeptide Y and its C-terminal fragments deposited onto colloidal gold nanoparticle surface08/29/2019
- Neuropeptide receptors as potential pharmacological targets for obesity08/28/2019
- Pharmacological characterization of the cloned neuropeptide Y y6 receptor08/27/2019
- ReviewThe role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease☆08/26/2019
- Centrally injected neuropeptide Y (13–36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1–36) in the awake male rat08/25/2019
- Subchapter 25B - Neuropeptide Y08/24/2019
- Research ArticleNeuropeptide Y is Up-regulated and Induces Antinociception in Cancer-induced Bone Pain☆08/23/2019
- NeuroPeptide Y [13-36]08/22/2019
- Galanin(1-13)-Trp-32-Neuropeptide Y(25-36)Amide08/21/2019
-
Health and Chemical more >


